Hemodialysis vascular access and subsequent transplantation: a report from the ESPN/ERA-EDTA Registry

Michael Boehm1, Marjolein Bonthuis2, Marlies Noordzij3

  • 1Division of Pediatric Nephrology and Gastroenterology, Medical University of Vienna, Vienna, Austria.

Insights

Central venous catheters (CVC) are common for pediatric hemodialysis (HD) in Europe, despite guidelines favoring arteriovenous fistulas (AVF). AVF use is linked to better survival and fewer access switches in children needing HD.

Area of Science:

  • Pediatric Nephrology
  • Vascular Access for Hemodialysis
  • Renal Replacement Therapy

Background:

  • Current guidelines recommend arteriovenous fistula (AVF) over central venous catheter (CVC) for pediatric hemodialysis (HD).
  • Limited European data exist on vascular access practices, patient survival, and transplantation outcomes in children undergoing HD.

Purpose of the Study:

  • To analyze current practices in vascular access choice for children starting HD in Europe.
  • To investigate factors influencing vascular access selection and switching.
  • To evaluate the impact of vascular access type on patient survival and transplant outcomes.

Main Methods:

  • Analysis of incident pediatric HD patients from 18 European countries (2000-2013) from the ESPN/ERA-EDTA Registry.
  • Descriptive statistics, logistic and Cox regression, and competing risk analysis were used.
  • Vascular access type, patient demographics, and transplant data were evaluated.

Main Results:

  • 55.1% of children initiated HD with a CVC, associated with younger age and specific diagnoses.
  • AVF patients had a 91% lower likelihood of switching access and showed higher two-year survival (99.6% vs 97.2% for CVC).
  • Starting with AVF was associated with lower odds of living donor transplant but higher odds of deceased donor transplant.

Conclusions:

  • CVC remains the predominant vascular access for European children starting HD.
  • Choice of CVC may be influenced by referral timing, rapid ESRD onset, young age, and anticipated short time to transplant.
  • Further research is needed on how vascular access type affects living versus deceased donor transplantation patterns.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.7K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
815
EDTA: Chemistry and Properties01:22

EDTA: Chemistry and Properties

Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
3.4K
Data Reporting and Recording01:24

Data Reporting and Recording

Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.4K
EDTA: Conditional Formation Constant01:09

EDTA: Conditional Formation Constant

Each EDTA molecule has six binding sites: four carboxyl groups and two amino groups. The fully protonated form of EDTA is represented as H6Y2+. However, it can exist in different forms, H5Y+, H4Y, H3Y−, H2Y2−, and HY3−, depending on the pH of the solution. In very basic solutions with pH > 10.17, the fully deprotonated form, Y4−, is the predominant species that readily complexes with metal ions in a 1:1 ratio.
For the equilibrium reaction of the metal with the...
2.1K
EDTA: Auxiliary Complexing Reagents01:26

EDTA: Auxiliary Complexing Reagents

EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
1.4K